Vortrag am FONDS professionell KONGRESSUBS (Lux) Equity Fund - Biotech (USD), Anteilsklasse P-acc, USD
| MVD-Fonds Rating | EDA |
|---|---|
  | 75 |
ISIN: LU0069152568 | WKN: 986327
KAG: UBS Fund M. (LU)
NAV: 764,58 USD am 21.08.2024
Portfolio
Watchlist
KursalarmAnlageschwerpunkt UBS (Lux) Equity Fund - Biotech (USD), Anteilsklasse P-acc, USD
Größte Positionen
 | REGENERON PHARMAC.DL-,001 | 9,85% |
 | ALNYLAM PHARMACE.DL-,0001 | 9,69% |
 | VERTEX PHARMAC. DL-,01 | 9,30% |
 | MODERNA INC. DL-,0001 | 7,00% |
 | NEUROCRINE BIOSCI. DL-001 | 4,69% |
 | AMGEN INC. DL-,0001 | 4,58% |
 | GUARDANT HEALTH CL. A | 4,26% |
 | BLUEPRINT MED.CORP.DL-001 | 3,89% |
 | GENMAB AS DK 1 | 3,69% |
 | ABBVIE INC. DL-,01 | 3,47% |
